Original Report

The impact of myelodysplastic syndromes on quality of life: lessons learned from 70 voices


 

Background Little is known about the impact of myelodysplastic syndromes (MDS) on the quality of life (QoL) of those living with the disease.

Objectives To explore the impact of MDS on the quality of life of those living with the disease.

Methods Seventy patients with MDS participated in five focus groups conducted throughout the United States. Transcripts from recordings of focus group sessions were coded and emerging themes identified using thematic analysis.

Results Findings revealed a multifaceted description of how MDS affects QoL. MDS was found to cause a substantial and sustained decrease in ability to function. QoL was adversely affected by work expended on managing the disease. The emotional impact was often viewed as more problematic than the physical impact; emotional reactions included shock, anger, depression, and anxiety. In contrast, spiritual well-being was often enhanced, with a renewed appreciation for life, relationships, and faith.

Limitations The method of subject recruitment may have limited participation to individuals who are more proactive in obtaining information about their illness. The focus groups convened only once, thus purposive sampling and repeated assessments were not possible.

Conclusions MDS has a substantial, often negative impact on patients' lives and clinicians should be cognizant of this impact. Attention must be directed at providing more comprehensive support for the patient throughout the illness trajectory.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Program Curbs Shoulder Morbidity Post Breast Cancer
MDedge Hematology and Oncology
Heparin Bridging Associated With Increased Bleeding Risk
MDedge Hematology and Oncology
IGF-I Doesn't Predict Late Complications in Childhood Cancer Survivors
MDedge Hematology and Oncology
Prostate Cancer Deaths: Annual Screen Not Superior to Usual Care
MDedge Hematology and Oncology
Family and Caregiver Needs Over the Course of the Cancer Trajectory
MDedge Hematology and Oncology
REVIEW: Comprehensive Management of Respiratory Symptoms in Patients with Advanced Lung Cancer
MDedge Hematology and Oncology
PEER VIEWPOINT: Targeting the Symptoms of Lung Cancer, Not Just the Disease
MDedge Hematology and Oncology
PEER VIEWPOINT: Respiratory Symptoms in Advanced Lung Cancer: A Persistent Challenge
MDedge Hematology and Oncology
Managing Side Effects of Tyrosine Kinase Inhibitor Therapy to Optimize Adherence in Patients with Chronic Myeloid Leukemia: The Role of the Midlevel Practitioner
MDedge Hematology and Oncology
Determinants of Physical Activity in Palliative Cancer Patients: An Application of the Theory of Planned Behavior
MDedge Hematology and Oncology